Biodexa Pharmaceuticals PLC (BDRX)
4.67
+0.27
(+6.14%)
USD |
NASDAQ |
Nov 22, 11:24
Biodexa Pharmaceuticals Total Liabilities (Quarterly): 6.628M for June 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 6.628M |
| June 30, 2024 | 6.628M |
| December 31, 2023 | 7.470M |
| June 30, 2023 | 3.358M |
| June 30, 2023 | 3.358M |
| December 31, 2022 | 2.859M |
| June 30, 2022 | 2.657M |
| June 30, 2022 | 2.657M |
| December 31, 2021 | 3.321M |
| June 30, 2021 | 6.259M |
| June 30, 2021 | 6.259M |
| December 31, 2020 | 4.223M |
| June 30, 2020 | 9.170M |
| June 30, 2020 | 9.170M |
| December 31, 2019 | 14.86M |
| Date | Value |
|---|---|
| June 30, 2019 | 4.794M |
| June 30, 2019 | 4.794M |
| December 31, 2018 | 4.466M |
| June 30, 2018 | 16.31M |
| June 30, 2018 | 16.31M |
| December 31, 2017 | 19.66M |
| June 30, 2017 | 11.02M |
| June 30, 2017 | 11.02M |
| December 31, 2016 | 13.47M |
| June 30, 2016 | 21.37M |
| June 30, 2016 | 21.37M |
| December 31, 2015 | 25.41M |
| June 30, 2015 | 8.083M |
| June 30, 2015 | 8.083M |
| December 31, 2014 | 7.275M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
2.657M
Minimum
Jun 2022
14.86M
Maximum
Dec 2019
5.926M
Average
6.259M
Median
Jun 2021
Total Liabilities (Quarterly) Benchmarks
| Adaptimmune Therapeutics PLC | 237.45M |
| Verona Pharma PLC | 251.33M |
| NuCana PLC | 20.58M |
| Autolus Therapeutics PLC | 350.52M |
| TC BioPharm (Holdings) PLC | 7.807M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 17.67M |
| Shareholders Equity (Quarterly) | 11.04M |